Skip to content

    Asthma Health Center

    Font Size
    A
    A
    A

    Analysis Shows No Singulair, Suicide Link

    Study Suggests Early Improvement in Emotional Well-Being
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    Sept. 5, 2008 -- A new analysis by the American Lung Association does not support a link between the asthma and allergy drug Singulair and depression and suicide.

    Researchers combined data from three blinded, case-control studies involving 1,352 children and adults who took either Singulair or placebo.

    They found no evidence of deteriorating emotional well-being among users of the asthma and allergy drug.

    In fact, the drug seemed to have an opposite effect early in treatment in one trial, with Singulair users scoring higher than placebo users in tests designed to measure emotional status.

    (With the conflicting studies and reports, how are you feeling about this drug right now? Talk with others on WebMD's Asthma: Support Group board.)

    Findings 'Reassuring'

    Approved by the FDA a decade ago, Singulair has become one of drugmaker Merck's top-selling products, with sales of $4.4 billion last year.

    But last March, FDA officials launched an investigation of largely anecdotal reports suggesting a link between the drug and suicidal thoughts and behaviors. The investigation was expected to take nine months.

    ALA Chief Medical Officer Norman Edelman, MD, says the new analysis should reassure the millions of people who take Singulair.

    "I think there is good evidence that Singulair does not cause depression," he tells WebMD. "We can't say this with absolute certainty, but this goes a long way toward answering the question."

    The analysis will be presented in a letter to be published in an upcoming issue of the Journal of Allergy and Clinical Immunology.

    Researchers Janet Holbrook, PhD, and Raida Harik-Khan, PhD, combined data from the three ALA-funded trials conducted at 20 research centers across the country.

    The original aim of the studies, which included children and adults, was to determine how best to manage asthma symptoms with available treatments, Edelman says. But the studies also included quality of life and emotional well-being assessments for 536 patients treated with Singulair and 816 patients who did not take Singulair.

    Adults in the studies were followed for two to 24 weeks and the children were followed for four to 16 weeks.

    When Is Your Asthma Worse?

    When Is Your Asthma Worse?

    Take the WebMD Asthma assessment to get Personalized Action Plan

    Start Now

    Today on WebMD

    Lung and bronchial tube graphic
    5 common triggers.
    group jogging in park
    Should you avoid fitness activities?
     
    asthma inhaler
    Learn about your options.
    man feeling faint
    What’s the difference?
     
    Madison Wisconsin Capitol
    Slideshow
    woman wearing cpap mask
    Article
     
    red wine pouring into glass
    Slideshow
    Woman holding inhaler
    Quiz
     
    Man outdoors coughing
    Article
    Lung and bronchial tube graphic
    Article
     
    10 Worst Asthma Cities
    Slideshow
    runner
    Article